450 related articles for article (PubMed ID: 27475987)
21. Importance of using relapse studies or tests for detection of antibiotic resistance before considering that a treatment for multidrug-resistant enterococcal experimental endocarditis is effective.
Caron F
J Infect Dis; 1997 Jan; 175(1):232-3. PubMed ID: 8985229
[No Abstract] [Full Text] [Related]
22. Evolving resistance among Gram-positive pathogens.
Munita JM; Bayer AS; Arias CA
Clin Infect Dis; 2015 Sep; 61 Suppl 2(Suppl 2):S48-57. PubMed ID: 26316558
[TBL] [Abstract][Full Text] [Related]
23. Treatment of infections caused by antimicrobial-resistant gram-positive bacteria.
Kinney KK
Am J Med Sci; 2010 Sep; 340(3):209-17. PubMed ID: 20823699
[TBL] [Abstract][Full Text] [Related]
24. Glycopeptide resistance in gram-positive pathogens.
Fraimow HS; Shlaes DM
Adv Exp Med Biol; 1995; 390():81-95. PubMed ID: 8718604
[No Abstract] [Full Text] [Related]
25. [Antibiotic resistance, a cross-functional issue (One Health)].
Madec JY
Rev Infirm; 2023 Oct; 72(294):24-26. PubMed ID: 37838366
[TBL] [Abstract][Full Text] [Related]
26. Gram-positives towards the year 2000.
Moellering RC
Drugs; 1997; 54 Suppl 6():1-3. PubMed ID: 9474475
[No Abstract] [Full Text] [Related]
27. Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
S D J Med; 1998 Apr; 51(4):127-32. PubMed ID: 9577692
[No Abstract] [Full Text] [Related]
28. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
Chow JW; Donahedian SM; Zervos MJ
Clin Infect Dis; 1997 Jan; 24(1):90-1. PubMed ID: 8994759
[No Abstract] [Full Text] [Related]
29. Antibiotic resistance.
Cuddy ML
J Pract Nurs; 2005; 55(3):11-7; quiz 18. PubMed ID: 16355726
[No Abstract] [Full Text] [Related]
30. Treatment of gram-positive surgical sepsis: role of the oxazolidinones.
Colizza S; Rossi S; Rodio F; Carnuccio P; Cucchiara G
J Chemother; 2003 Aug; 15(4):323-8. PubMed ID: 12962359
[TBL] [Abstract][Full Text] [Related]
31. [Antibacterial drug resistance in Latin America: consequences for infectious disease control].
Casellas JM
Rev Panam Salud Publica; 2011 Dec; 30(6):519-28. PubMed ID: 22358396
[TBL] [Abstract][Full Text] [Related]
32. Emerging glycopeptide resistance in gram-positive organisms.
von Gottberg A; Ferraz V; Dusé AG
S Afr Med J; 2000 Nov; 90(11):1108-9. PubMed ID: 11196027
[No Abstract] [Full Text] [Related]
33. [Novel antibiotics active against Gram-positive bacteria].
Garcia Sánchez JE; Fresnadillo Martínez MJ
Rev Esp Quimioter; 2000 Dec; 13(4):344-51. PubMed ID: 11498700
[No Abstract] [Full Text] [Related]
34. Vancomycin-resistant Enterococcus faecium meningitis successfully treated with chloramphenicol.
Pérez Mato S; Robinson S; Bégué RE
Pediatr Infect Dis J; 1999 May; 18(5):483-4. PubMed ID: 10353532
[No Abstract] [Full Text] [Related]
35. New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.
MacConnachie AM
Intensive Crit Care Nurs; 1999 Aug; 15(4):239-41. PubMed ID: 10786510
[TBL] [Abstract][Full Text] [Related]
36. [Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Bogomolova NS; Bol'shakov LV; Kuznetsova SM; Oreshkina TD
Antibiot Khimioter; 2011; 56(5-6):37-45. PubMed ID: 22145229
[TBL] [Abstract][Full Text] [Related]
37. Biofilms: Microbial Shelters Against Antibiotics.
Hathroubi S; Mekni MA; Domenico P; Nguyen D; Jacques M
Microb Drug Resist; 2017 Mar; 23(2):147-156. PubMed ID: 27214143
[TBL] [Abstract][Full Text] [Related]
38. [Bacterial resistance during anti-acne antibiotic therapy. How to limit the risk].
Piérard GE; Arrese JE; Claessens N; Greimers R; Piérard-Franchimont C; Naeyaert JM
Rev Med Liege; 1999 Feb; 54(2):100-4. PubMed ID: 10221062
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance among gram-positive organisms in the intensive care unit.
Clark NM; Hershberger E; Zervosc MJ; Lynch JP
Curr Opin Crit Care; 2003 Oct; 9(5):403-12. PubMed ID: 14508154
[TBL] [Abstract][Full Text] [Related]
40. Clinical aspects of antimicrobial resistance.
Virk A; Steckelberg JM
Mayo Clin Proc; 2000 Feb; 75(2):200-14. PubMed ID: 10683663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
